Dangan, Kate Millary .

HRN: 22-63-14  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2026
CEFUROXIME 1.5GM (VIAL)
06/18/2026
06/25/2026
IV
345mg
Q8h
Uti
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: